CDK inhibitor E9
CDK inhibitor E9 is a novel CDK inhibitor that can overcomes ABC-mediated resistance of THZ1, functions as a potent, non-covalent inhibitor of CDK9 and a covalent inhibitor of CDK12.
Product Specifications
Stability
≥ 2 years
Purity
>98% (HPLC)
Weight
434.544
Molecular Formula
C24H30N6O2
Notes
Research use only, not for human use.
Receptor
CDK
CAS Number
2020052-55-3
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
MBS1379746-01 0.02 mg (E-Coli)
Recombinant Rat Cbp/p300-interacting transactivator 4 (Cited4)
Ask
View Details 
MBS1379746-02 0.1 mg (E-Coli)
Recombinant Rat Cbp/p300-interacting transactivator 4 (Cited4)
Ask
View Details MBS1379746-03 0.02 mg (Yeast)
Recombinant Rat Cbp/p300-interacting transactivator 4 (Cited4)
Ask
View Details 
MBS1379746-04 0.1 mg (Yeast)
Recombinant Rat Cbp/p300-interacting transactivator 4 (Cited4)
Ask
View Details MBS1379746-05 0.02 mg (Baculovirus)
Recombinant Rat Cbp/p300-interacting transactivator 4 (Cited4)
Ask
View Details MBS1379746-06 0.02 mg (Mammalian-Cell)
Recombinant Rat Cbp/p300-interacting transactivator 4 (Cited4)
Ask
View Details